Research and experimental development on biotechnology (PKD 72.11.Z)2007
Industry statistics (2025)
Number of companies
Companies
11,023
Companies (primary PKD)
970
Companies with financials
455
Business turnover
Legal structure
Legal formShare of companiesNumber of companies
- Sp. z o.o.74.5%723
- JDG6.7%65
- S.A.5.4%52
- Foundation4.5%44
- P.S.A.2.4%23
- Sp. k.2.1%20
- Sp. j.1.6%16
- Other1.3%13
- Association0.8%8
- Sp. p.0.2%2
- Cooperative0.1%1
Financial results
The calculation excludes new companies that pull financial results down. Only firms with a filing in the previous year are included, so market trends are easier to read.
Median revenue
Ranking
Median revenue compared with other PKD codes.
Top companies by revenue
| # | Company | Legal form | Revenue | Net profit |
|---|---|---|---|---|
| 1 | Research institute | USD 415.31m | USD -2.38m | |
| 2 | Research institute | USD 354.37m | USD 14.67k | |
| 3 | sp. z o.o. | USD 26.31m | USD 1.53m | |
| 4 | sp. z o.o. | USD 21.73m | USD 2.60m | |
| 5 | S.A. | USD 17.68m | USD 605.64k | |
| 6 | Research institute | USD 10.98m | USD -46.64k | |
| 7 | sp. z o.o. | USD 6.39m | USD 1.05m | |
| 8 | Research institute | USD 6.00m | USD 463.74k | |
| 9 | sp. z o.o. | USD 5.85m | USD 445.83k | |
| 10 | Foundation | USD 4.64m | USD 3.40k |
Fastest-growing companies
| # | Company | Legal form | Revenue | Y/Y growth |
|---|---|---|---|---|
| 1 | sp. z o.o. | USD 4.01m | +1,165.7% y/y | |
| 2 | sp. z o.o. | USD 915.04k | +909.8% y/y | |
| 3 | S.A. | USD 381.18k | +496.1% y/y | |
| 4 | sp. z o.o. | USD 288.62k | +448.7% y/y | |
| 5 | sp. z o.o. | USD 418.75k | +418.3% y/y | |
| 6 | sp. z o.o. | USD 456.93k | +315.0% y/y | |
| 7 | sp. z o.o. | USD 449.21k | +262.0% y/y | |
| 8 | S.A. | USD 501.81k | +223.7% y/y | |
| 9 | sp. z o.o. | USD 663.51k | +218.2% y/y | |
| 10 | sp. z o.o. | USD 1.83m | +135.6% y/y |
Stock market
7 companies from this industry are listed.
| Company | Ticker | Market | Price | Change | Market cap |
|---|---|---|---|---|---|
| MQR | GPW Main Market | PLN 1.54 | +1.86% | USD 86.69m | |
| URT | GPW Main Market | PLN 42.80 | 0.00% | USD 16.33m | |
| RDG | NewConnect | PLN 5.00 | -0.79% | USD 14.74m | |
| GMT | GPW Main Market | PLN 2.98 | +2.76% | USD 12.71m | |
| MDA | NewConnect | PLN 0.17 | -5.28% | USD 10.66m | |
| SDS | NewConnect | PLN 3.50 | -3.31% | USD 5.84m | |
| GX1 | NewConnect | PLN 5.76 | +8.68% | USD 4.76m |
Related PKD codes in division 72
FAQ
The primary industry for 970 companies is research and experimental development on biotechnology. 455 entities have filed financial statements.
In 2024, 52 new companies with PKD 72.11.Z were registered. In all of 2023, there were 63 such companies.
In 2024, 42 companies with PKD 72.11.Z were deregistered. In all of 2023, there were 29 such companies.
In 2025, the median revenue for PKD 72.11.Z was USD 87.56k and the mean revenue was USD 4.03m, based on 239 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.
No, in 2025, the median net result was USD -237.00, though that is an improvement on 2024 (USD -1.27k). Among all 904 industries in Poland, PKD 72.11.Z ranks 861st, placing it among the weakest 4.8%.
The most common legal form for PKD 72.11.Z is sp. z o.o., used by 723 companies in this industry (74.5% of the total). In second place is a sole proprietorship (65 companies, 6.7%), and in third place – S.A. (52 companies, 5.4%).















